Paid Clinical Trials Ann Arbor

Discover 1,907 paid clinical trials in Ann Arbor, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,907

Asthma Research Study for Ages 12–17Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Detroit MI, Toledo OH, Columbus OH, Dayton OHshow 70 more

Code:

NCT06307665

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

BDA MDI

AS MDI

Olvimulogene Nanivacirepvec & Platinum-doubletEfficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Recruiting

PHASE2

Sponsor:

Genelux Corporation

Location:

Farmington Hills MI, Dearborn MI, Orange City FL, Clermont FLshow 3 more

Code:

NCT06463665

Conditions

Advanced Non-squamous Non-small-cell Lung Cancer

Advanced Squamous Non-Small Cell Lung Carcinoma

Metastatic Non-squamous Non Small Cell Lung Cancer

Metastatic Squamous Non-Small Cell Lung Carcinoma

Non-small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Olvimulogene nanivacirepvec

Platinum chemotherapy: carboplatin or cisplatin

Non-platinum chemotherapy: paclitaxel or nab-paclitaxel for squamous cell NSCLC or pemetrexed for nonsquamous cell NSCLC

Physician's Choice of Immune Checkpoint Inhibitor: pembrolizumab, nivolumab, cemiplimab, atezolizumab, durvalumab

Docetaxel

CryoablationCryoablation for Monomorphic Ventricular Tachycardia

Recruiting

Sponsor:

Adagio Medical

Location:

Ann Arbor MI, Columbus OH, Baltimore MD, Nashville TNshow 9 more

Code:

NCT05675865

Conditions

Sustained VT

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

cryoablation procedure

IanalumabTwo-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease

Recruiting

PHASE2

Sponsor:

Novartis Pharmaceuticals

Location:

Grand Blanc MI, Middleburg Heights OH, Indianapolis IN, Duncansville PAshow 14 more

Code:

NCT06293365

Conditions

Sjögrens Disease

Systemic Lupus Erythematosus

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

VAY736 1ml PFS

VAY736 2 ml PFS

VAY736 2ml AI

PovorcitinibA Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

Recruiting

PHASE3

Sponsor:

Incyte Corporation

Location:

Ann Arbor MI, Waterford MI, Detroit MI, Fort Gratiot MIshow 47 more

Code:

NCT06516965

Conditions

Prurigo Nodularis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Povorcitinib

Placebo

Observational StudyProstate Active Surveillance Study

Recruiting

Sponsor:

University of Washington

Location:

Ann Arbor MI, Norfolk VA, Atlanta GA, Boston MAshow 5 more

Code:

NCT00756665

Conditions

Prostatic Neoplasms

Eligibility Criteria

Sex: Male

Age: 21+

Healthy Volunteers: Not accepted

Nivolumab & TovorafenibNivolumab and Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

Recruiting

PHASE2

Sponsor:

Sabine Mueller, MD, PhD

Location:

Ann Arbor MI, Chicago IL, Indianapolis IN, Saint Louis MOshow 11 more

Code:

NCT05465174

Conditions

Craniopharyngioma, Child

Craniopharyngioma

Recurrent Craniopharyngioma

Eligibility Criteria

Sex: All

Age: 1 - 39

Healthy Volunteers: Not accepted

Interventions

Nivolumab

Tovorafenib

ONC206ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

Recruiting

PHASE1

Sponsor:

Sabine Mueller, MD, PhD

Location:

Ann Arbor MI, Philadelphia PA, Atlanta GA, San Francisco CA

Code:

NCT04732065

Conditions

Diffuse Midline Glioma (DMG)

Glioblastoma

Recurrent Ependymoma

Recurrent Malignant Central Nervous System Neoplasm

Spinal Cord Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

ONC206

Standard of Care Radiation Therapy

Optional Proton (1H) MR spectroscopy (MRS)

GDNF Gene TherapyGDNF Gene Therapy for Multiple System Atrophy

Recruiting

PHASE1

Sponsor:

Brain Neurotherapy Bio, Inc.

Location:

Farmington Hills MI, Columbus OH, Nashville TN, New York NYshow 3 more

Code:

NCT04680065

Conditions

Multiple System Atrophy

Eligibility Criteria

Sex: All

Age: 35 - 70+

Healthy Volunteers: Not accepted

Interventions

AAV2-GDNF gene therapy

Sham (Placebo) Surgery

WaterWorks® Douching DeviceEfficacy of (WaterWorks®)Douching Device for Elimination of Perceived Vaginal Odor Not Caused by BV or Vaginitis

Recruiting

Sponsor:

Abbott Research Group

Location:

Detroit MI, Winston Salem NC, Philadelphia PA, Atlanta GAshow 3 more

Code:

NCT00417365

Conditions

Vaginal Odor

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

WaterWorks Douching Device